{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.264","value":"1.95"},{"groupId":"OG001","spread":"0.144","value":"-0.36"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"237"},{"groupId":"OG001","value":"237"}],"units":"Participants"}],"description":"The modified vdH-S score is a radiographic evaluation of hand and feet erosions and joint space narrowing (JSN) for 20 joints per hand and 6 joints per foot with a total score ranging from 0 (best) to 528 (worst = worst possible erosion score of 320 + worst possible JSN score of 208). Higher score and positive score changes indicate more radiographic damage and radiographic progression, respectively.","dispersionType":"Standard Error","groups":[{"description":"Participants received intravenous infusions of placebo at Weeks 0, 4, 12 and 20.","id":"OG000","title":"Placebo"},{"description":"Participants were randomized to receive intravenous infusions of golimumab 2 mg/kg at Weeks 0, 4 and thereafter every 8 weeks up to Week 52. At Week 24, participants received a placebo infusion to maintain the blind.","id":"OG001","title":"Golimumab"}],"paramType":"MEAN","populationDescription":"FAS for structural damage endpoints (FAS-SD) defined as participants in the FAS who were treated and had a non-missing baseline total modified vdH-S score for the analysis.","reportingStatus":"POSTED","timeFrame":"Baseline and Week 24","title":"Change From Baseline in Total Modified Van Der Heijde-Sharp (vdH-S) Score at Week 24","type":"SECONDARY","unitOfMeasure":"units on a scale"}